Physician profile
Robert D Mcardle
NPI 1073625356
$2,825.25
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $384 · 2021: $585 · 2022: $389 · 2023: $273 · 2024: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $344 · Education: $35.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.88 |
| Education | $35.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,149.24 | 2019-2024 | Breztri, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $478.05 | 2019-2023 | Ofev |
| Glaxosmithkline, LLC. | $410.77 | 2019-2024 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $202.86 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $181.81 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.76 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $54.28 | 2023-2024 | Acthar |
| Abbvie INC. | $43.92 | 2022 | |
| Mylan Specialty L.P. | $34.43 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $32.18 | 2020 | |
| Astellas Pharma US INC | $29.53 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $29.42 | 2019 | |
| Grifols USA, LLC | $21.03 | 2019 | |
| Harmony Biosciences LLC | $19.38 | 2020 | |
| Philips North America LLC | $16.76 | 2024 | (Ak6) Vest Therapy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.83 | 2019 | |
| Circassia INC. | $13.50 | 2020 | |
| Allergan, INC. | $12.77 | 2020 | |
| Genentech USA, INC. | $12.53 | 2019 | |
| Amgen INC. | $12.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mcardle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.